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Abstract
Background—Nonmedical prescription opioid use (NMPOU) is well documented among 
participants in the club scene, yet prior studies have not examined transition to heroin use. We 
prospectively examined heroin initiation among a sample of young adults with drug involvement 
associated with participation in the club scene, to understand factors that influence transition from 
NMPOU to heroin and to identify opportunities for intervention.
Methods—Data were drawn from a randomized trial that enrolled 750 Miami-based club and 
prescription drug users through respondent driven sampling, and tested the efficacy of assessment 
interventions in reducing risk. Participants reported current substance use at baseline, 3, 6, and 12 
month follow-ups. We examined predictors of heroin initiation among participants reporting 
NMPOU at baseline, with no lifetime history of heroin use (N=323).
Results—The mean age was 25.0 years; 67.5% met DSM-IV criteria for substance dependence. 
About 1 in 13 participants (7.7%) initiated heroin use at follow-up. In univariable comparisons, 
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frequent LSD use, history of drug overdose, high frequency NMPOU, using oral tampering 
methods, and endorsing a primary medical source for prescription opioids were associated with 
greater likelihood of heroin initiation. LSD use, oral tampering, and primary medical source were 
significant predictors in a Cox regression model.
Conclusions—Heroin initiation of 7.7% suggests a high level of vulnerability for transition 
among young adult NMPO users in the club scene. The importance of oral tampering methods in 
the trajectory of NMPOU may indicate a need to further examine the role of abuse deterrent 
formulations in prevention efforts.
Keywords
young adults; club drugs; opioids; heroin; routes of administration; nonmedical use
1.0 Introduction
Nonmedical prescription opioid use (NMPOU) contributes to significant morbidity and 
mortality in the US (Compton et al., 2016), including dependence, overdose (Volkow and 
McLellan, 2016), exposure to blood-borne infections (Peters et al., 2016), and neonatal 
abstinence syndrome (Stover and Davis, 2015). Although the dramatic rise in NMPOU that 
occurred nationally from 1990 to 2010 has stabilized in recent years, the prevalence of 
prescription opioid use disorders and related mortality have continued to rise (Han et al., 
2015; Martins et al., 2017). Young adults have been especially impacted: in 2014, 20.2% of 
18–25 year olds reported lifetime NMPOU (Center for Behavioral Health Statistics and 
Quality, 2015), a higher prevalence than any other age group. National surveillance data also 
indicate that an increasing number of young adults are heavy prescription opioid users 
(Jones, 2013), which has been associated with higher drug problem severity and more rapid 
progression to dependence (Daniulaitye et al., 2006).
Recent efforts to characterize the evolving opioid problem indicate a broad shift from 
prescription opioids to heroin in many areas, with increasing rates of heroin use and heroin 
overdose seen nationally as early as 2009 (Cicero et al., 2014; Compton et al., 2016; Muhuri 
et al., 2013). To a large extent, this shift has occurred in an environment of increased efforts 
to reduce the adverse consequences of prescription opioids (Compton et al., 2016), including 
improved prescriber education (Alford et al., 2015; ONDCP, 2014), strengthening of 
prescription drug monitoring programs (Brady et al., 2014; Davis et al., 2014; Surratt et al., 
2014), targeted law enforcement activities (Florida Department of Law Enforcement, 2012; 
Hall, 2015; Surratt et al., 2014), abuse-deterrent opioid formulations (Cicero et al., 2012a), 
the development and implementation of opioid prescribing guidelines (Frieden and Houry, 
2016), and stewardship programs in healthcare settings to reduce the supply of opioids 
(Ghafoor et al., 2013). Although there is evidence to suggest that these types of initiatives 
have contributed to reductions in NMPOU and diversion of prescription opioids (Delcher et 
al., 2015; Rutlow et al., 2015; Surratt et al., 2014) their role in rising heroin use is unclear. 
Observational data indicate that heroin use was increasing prior to many of these initiatives 
being implemented (Dart et al., 2015; Dasgupta et al., 2014).
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A comprehensive understanding of the ordering, progression, transition, and/or co-occurring 
use of prescription opioids and heroin is lacking in the scientific literature, and represents an 
under-researched area with significant public health implications (Muhuri et al., 2013). 
National trend data demonstrate consistent connections between NMPOU and transition to 
heroin use, with heroin incidence some 19 times higher among those reporting prior 
nonmedical prescription opioid use than among those who do not (Muhuri et al., 2013). 
Adolescents and young adults appear to be especially vulnerable to the migration from 
prescription opioids to heroin (Cerda et al., 2015; Palamar et al., 2016). Trend data from 
2002 to 2014 documented a significant temporal increase in the odds of heroin use among 
young adults reporting prior non-medical prescription opioid use (Martins et al., 2017). 
Although strong evidence suggests clear linkages between the two phenomena (Carlson et 
al., 2016), it has been noted that heroin use among NMPO users is rare overall, and the 
transition to heroin use appears to occur at a low rate (Jones, 2013).
Emerging research is examining the intersections of NMPOU and heroin use to better 
understand the factors that may drive transitions. Carlson and colleagues (2016) conducted a 
prospective natural history study of young adult illicit prescription opioid users who at 
baseline were not opioid dependent and had no history of heroin use. Among this sample, 
7.5% initiated heroin over a 36-month period. Key predictors of transition included route of 
opioid administration, early age of prescription opioid administration, and lifetime 
prescription opioid dependence (Carlson et al., 2016). Additional explanatory factors posited 
in prior research to impact this transition include frequency of NMPOU (Jones, 2013; 
Palamar et al., 2016), tolerance and dependence (Daniulaitye et al., 2006, Haracopos et al., 
2016), market dynamics, and subjective aspects of the user experience (Cicero et al., 2014; 
Cicero and Ellis, 2015).
Route of administration appears to be an important contributor to the adverse health 
consequences associated with NMPOU (Katz et al., 2008; Surratt et al., 2011), including 
transition to heroin (Carlson et al., 2016). Non-oral routes of prescription opioid ingestion 
are not uncommon in samples of high school and college students, rural drug abusers and 
urban street drug users (Davis and Johnson 2008; McCabe et al., 2007; 2009; Surratt et al., 
2011; Young et al., 2010) and club drug users (Buttram and Kurtz, 2016), and are associated 
with greater drug problem severity, including dependence and overdose, and sexual risk 
behaviors (Buttram and Kurtz, 2016). Because altered routes of administration provide faster 
drug delivery and onset, the reinforcing effects are intensified (Compton and Volkow, 2006), 
thereby increasing the vulnerability to addiction. Trajectory analyses of NMPOU suggest 
that individuals often initiate with oral use and move to more efficient routes, such as 
snorting and smoking, as tolerance develops (Compton et al., 2016).
Although national surveillance data and focused studies involving community samples of 
young adults provide evidence for a transitional pathway from NMPOU to heroin (Carlson 
et al., 2016; Martins et al., 2017), it is important to document rates of heroin initiation in 
potentially vulnerable targeted samples to identify potential need and opportunities for 
intervention. NMPOU is well documented among participants in the club scene (Inciardi et 
al., 2007; Kelly and Parsons, 2007; Kelly et al., 2015; Kurtz et al., 2005; 2013; 2017), yet 
prior studies have not systematically examined transition to heroin use among samples of 
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club drug users. We prospectively examine the initiation of heroin use among a targeted 
sample of young adults with extensive, yet largely recreational, drug involvement associated 
with nightlife participation in the Miami club scene. Our key purposes are to investigate the 
initiation of heroin use over time among club goers who report NMPOU and to examine 
predictors of this transition that are potentially amenable to intervention.
2.0 Methods
2.1. Study Site
Miami-Dade County, Florida is a large and ethnically diverse metropolitan area with a 
population of 2.6 million people, of whom 66.2% are Hispanic (U.S. Census Bureau, 2015). 
For decades Miami has been a key transportation hub and distribution center for illicit drugs 
(Allman,1987; National Drug Intelligence Center, 2003; Portes and Stepick, 1993), and is a 
major presence in the U.S. East Coast club scene, having become well-known for 
trendsetting nightlife and club drug use (Brandt, 2003; Perrone, 2009). The Miami club 
scene is characterized by extensive poly-drug use among its largely young aged club-goers, 
typically including illicit drugs and nonmedical prescription drug use as features of the club 
going experience (Kurtz et al., 2005; 2013; 2017).
2.2 Study Sampling Plan
The data for this analysis were drawn from a prospective three-armed randomized controlled 
trial designed to recruit a sample of 750 Miami-based club-going participants and test the 
relative efficacy of alternative low-intensity assessment interventions in reducing drug use 
and sexual risk behaviors at 3, 6 and 12 month follow-up. Eligibility criteria for trial 
participation were: 1) ages 18–39; 2) reported use of illicit club drug(s) at least three times 
in the past 3 months; 3) reported nonmedical use of a psychoactive prescription medication 
at least once in the past 3 months; 4) heterosexual vaginal and/or anal sex in the past 3 
months; 5) attendance at large local nightclubs at least once per month; 6) residence in 
metropolitan Miami; and 7) willingness to provide locator information. Endorsement of both 
past 90 day club drug use and nonmedical prescription drug use was required for inclusion 
in the intervention trial.
Study recruitment was conducted between September 2011 and November 2014 using 
respondent-driven sampling (RDS) techniques (Heckathorn, 1997). Seeds (initial 
respondents) were recruited through targeted outreach at Miami nightclub venues and 
contacts in the club scene derived from the authors’ prior Miami-based field studies. 
Miami‘s club scene is comprised of an extensive network of large and small nightclubs 
clustered largely in the geographically contiguous areas of South Beach and the City of 
Miami, which have been mapped previously by the study investigators. Each seed and 
subsequent participant was provided with recruitment coupons to give to other potentially 
eligible drug users in their social network. Consistent with RDS procedures, each 
participant-recruiter in this study was limited to five coupons.
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2.3 Study Procedures
The study field office location was selected for accessibility to the primary transportation 
routes in Miami. Field staff were bi-lingual (English/Spanish) age-peers of the target 
population with at least a Bachelor’s degree and one year of research experience, who were 
trained in all aspects of the research and human subjects’ protocols. Field staff screened 
potential study participants by telephone; those who were eligible and interested in 
participating were scheduled for enrollment at the field office. The enrollment visit included 
eligibility verification, written informed consent using procedures approved by the 
University institutional review board, and collection of locator information.
At baseline, all participants completed a brief Risk Behavior Inventory (RBI) assessing 
primary substance use and sexual behavior outcomes using an ACASI-based instrument that 
took 10–15 minutes to complete. Participants were randomized immediately thereafter to the 
three study arms: 1) an interviewer-administered comprehensive health and social risk 
assessment intervention (CAPI Intervention); 2) a self-administered assessment intervention 
with identical instrumentation (ACASI Intervention); and 3) a waitlist control condition 
(Control). Immediately after randomization, those assigned to the CAPI or ACASI arms 
continued with the full assessment protocols; waitlist controls did not complete a full 
baseline assessment. At 3-, 6- and 12-months post-baseline, all participants again completed 
the brief RBI measure of primary outcome data. At 12-month follow-up, based on initial 
intervention assignment, appropriate comprehensive health and social risk assessments were 
also completed. Participants received $50 for their time and travel costs for the baseline and 
each subsequent follow-up visit.
2.4 Measures
The assessment interventions utilized the Global Appraisal of Individual Needs (GAIN, v. 
5.4; Dennis et al., 2006), which has eight core sections (background, substance use, physical 
health, sexual risk behaviors, mental health, victimization, criminal justice involvement, and 
education/work/financial stability), each assessing recency of problems, range of symptoms, 
and recent (90 day) and lifetime prevalence. The items include scales for Diagnostic and 
Statistical Manual of Mental Disorders, 4th edition (DSM-IV)-based diagnoses. 
Psychometric studies have found Cronbach’s alphas between .8 and .9 for these measures. 
For the present study, the list of drugs was extended to include major classes of psychoactive 
prescription medications, and sexual behavior questions were substantially expanded using 
validated instruments.
2.5 Analytic Sample Selection
The present analysis examined prospective predictors of heroin initiation among club-going 
participants reporting NMPOU at baseline. Data for this analysis are limited to participants 
from the two active assessment intervention arms (N=498) who at baseline: 1) endorsed past 
90 day NMPOU (N=446; 89.5%); and, 2) denied any lifetime history of heroin use (N=369; 
74.1%), resulting in an available N of 323. Controls were excluded from the analysis due to 
the lack of baseline data on lifetime heroin use, as well as the NMPOU predictor variables of 
interest. Because the active intervention arms consisted of an equivalent low-intensity 
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assessment delivered in different modalities (CAPI versus ACASI), we prospectively 
compare identical data points, controlling for intervention arm assignment.
2.6. Dependent Variable
The primary outcome measure for this study was initial use of heroin as prospectively 
observed among NMPO users with no prior exposure to heroin. The point in time when 
NMPO users initiated heroin for the first time was assessed with the question “during the 
past 90 days, on how many days did you use heroin?” that was collected at three follow-up 
intervals: (1) the 3-month assessment, (2) the 6-month assessment, and (3) the 12-month 
assessment. If a participant reported one or more days of heroin use at a follow-up interval, 
the participant was considered to have experienced the event under study (heroin initiation) 
and the study interval when heroin use was first endorsed was indexed. Participants who 
reported zero days of heroin use across intervals followed were considered to “survived” in 
terms of continuing to have no exposure to heroin use. Participants were censored from the 
analysis at the study interval where they were missing data for this assessment. Sensitivity 
analysis for informative censoring showed no appreciable effects on findings, and mid-level 
censors (n=49) were representative of the sample at baseline.
2.7 Independent Variables
The primary independent variables for this analysis were demographics, physical and mental 
health status, substance use (including current use, past year dependence, and lifetime 
overdose, treatment and injection history) and specific features of NMPOU (length of 
NMPOU, frequency of NMPOU, routes of administration, and sources of opioid 
acquisition). The selection of independent variables for examination was largely guided by 
recent findings in the scientific literature documenting associations between aspects of 
NMPOU and heroin use initiation (Carlson et al., 2016; Cicero and Ellis, 2015; Lankenau et 
al., 2012). Although the role of physical and mental health issues in transition to heroin is 
unclear, there are well-documented connections between pain, depression and the 
development of opioid use disorders (Blanco et al., 2016; Salas et al., 2016). As such, we 
included physical and mental health measures as independent variables in our analysis.
Demographic measures included age, gender, and race/ethnicity. Race/ethnicity was 
assessed by asking participants to self-identify as Hispanic or Latino, followed by asking 
what race they considered themselves to be. Intervention arm was included as a background 
variable to test for intervention effects on the likelihood of heroin initiation.
For this analysis, current physical health status included two items. Physical pain was 
assessed by a single dichotomous item reporting whether the participant had experienced 
severe physical pain in the past 90 days. A second item asked participants to report whether 
they had experienced physical health problems that interfered with their ability to meet 
responsibilities in the past 90 days, as an indicator of health problem severity and impaired 
functioning.
Mental health status was measured using the GAIN’s General Mental Distress Scale 
(GMDS), which includes past year DSM-IV symptom counts of depression (9 items), 
anxiety (12 items), and somatic disorders (four items). Alpha reliability coefficients for the 
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depression, anxiety, and somaticism subscales in this study were 0.882, 0.887, and 0.801, 
respectively. The GMDS has established classifications indicating clinical significance - 
subclinical, moderate, and severe (Dennis et al., 2006). For this analysis, mental distress 
scores were dichotomized into “severe” (seven or more symptoms) and “not severe” for 
descriptive purposes.
Substance use measures included past 90-day frequencies, in days, of reported use of 
alcohol, marijuana, powder cocaine, crack, ecstasy, LSD, methamphetamine, and heroin, as 
well as the non-medical use of prescription benzodiazepines, stimulants, antidepressants and 
antipsychotics.
Substance dependence was assessed by seven DSM-IV symptoms experienced during the 
past year (e.g., using more or more often than intended, withdrawal problems), and was 
dichotomized as “dependent” (three or more symptoms) or “not dependent” for descriptive 
reporting. Single dichotomous items assessed lifetime prevalence of injection drug use and 
substance treatment history. Participants were asked about drug overdose histories with the 
following item: “How many times in your life, if ever, have you had a drug overdose or 
drug-related emergency?” Participants endorsing such histories were asked to report the 
number of times they had experienced a drug overdose or emergency, as well as the 
substances involved.
Several features of NMPOU were also examined as potential predictors of heroin initiation 
at follow up. As a general instruction, participants were directed not to report use of 
prescription opioids as instructed by a doctor. We examined length of NMPOU, calculated 
from reported age at initial NMPOU to present.
Following symptom assessment for DSM-IV dependence described above, participants were 
asked to indicate the main substance that caused each of these symptoms. Those indicating 
three or more past year symptoms attributed primarily to prescription opioids were classified 
as “dependent”. Frequency of NMPOU was assessed by asking participants to report the 
specific number of days they had used opioids non-medically within the 90 days prior to 
interview.
Routes of prescription opioid administration were assessed by the following item:
Please select all the ways you have used/taken prescription opioids in the past 90 
days. Response options included oral (drank, swallowing a whole pill, swallowing a 
crushed pill, dissolving under the tongue, and parachuting [swallowing a crushed pill 
inside a piece of paper]), smoked, snorted/sniffed, injected, and rectal/vaginal. For 
analysis, we examined oral intact (drank or whole pill), oral tampered (crushed pill, 
parachute, and under tongue), smoked, snorted and injected. Rectal/vaginal 
administration of prescription opioids was not endorsed by any participant in the 
selected sample.
Usual source of prescription opioid acquisition was measured by asking participants: In the 
past 90 days, what was the primary way you got your prescription opioids? Response 
choices were: more than one doctor, your regular doctor, pain clinic, theft, club/dealer/street 
buy, sharing/trading, internet, and other. For the purposes of analysis, we collapsed regular 
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doctor and pain clinic into a “medical source” category. More than 1 doctor and internet 
were not endorsed as primary sources for prescription opioids in the selected sample. For 
analysis, we examined “medical source” versus all other sources.
2.8 Data Analysis
Statistical analyses were conducted using IBM SPSS Statistics version 23 and SAS version 
9.3 (SAS Institute Inc., Cary, NC), using PROC PHREG and PROC LIFETEST procedures. 
Descriptive statistics were calculated for the variables of interest, including age, gender, 
race/ethnicity, physical and mental health, substance use and associated substance problems, 
including DSM-IV dependence symptoms, and NMPOU characteristics. Univariable 
comparisons (chi-square and t-tests) were performed to examine baseline characteristics of 
participants who did and did not initiate heroin use during the follow-up period. Univariable 
comparisons are not presented for indicators with fewer than 5 participant endorsements. 
Variables that distinguished heroin initiators from non-initiators (p-values <=.10) were 
selected for inclusion in a Cox proportional hazard regression analysis to determine the 
associations between baseline predictors in relation to likelihood of heroin initiation. In 
addition to controlling for intervention arm, the Cox regression model included demographic 
variables that have been associated with NMPOU and heroin use in prior research (Palamar 
et al., 2016). Kaplan-Meier survival estimates were used to calculate probabilities of time to 
heroin initiation. Inter-correlations between predictor variables were low (rs=.01–.30), and 
tests for the violation of the proportional hazard assumption found no evidence of non-
proportionality. All two-tailed tests with significant values greater than 95% (p<.05) are 
reported.
3.0 Results
Sample characteristics are displayed in Table 1. The overall sample of NMPO users was 
young, with a mean age of 25.0 years, and was 46.4% female. Nearly two-thirds (65.0%) 
were Hispanic, mirroring the ethnic composition of the Miami metropolitan area.
Despite the sample’s young age, physical health problems were prevalent among these 
heroin-naïve NMPO users. Nearly 30% of the sample reported experiencing significant pain 
during the 90 days prior to interview, and 22% reported that a physical health problem had 
impaired their daily functioning in the same time period. Prevalence of severe psychological 
distress was elevated at 48.6%. Less than 1% reported either an HIV or hepatitis C 
diagnosis.
In line with study eligibility criteria, NMPO users reported substantial polydrug use, 
including illicit club drug use and other nonmedical prescription drug use in the 90 days 
prior to interview. On average, reported use was most frequent for marijuana (63.2 days), 
alcohol (48.4 days), prescription sedatives (33.4 days), ecstasy (31.9 days), and powder 
cocaine (31.7 days).
In the context of heavy poly-drug use, indicators of substance use-related problems were 
also examined. More than two-thirds of the sample (67.5%) met DSM-IV criteria for 
substance dependence in the past year. 21.1% reported a drug overdose or drug-related 
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emergency in their lifetime, and half of those had experienced multiple overdose episodes 
(data not shown). Reported lifetime injection prevalence among NMPO users was 4.0%.
The sample reported NMPOU for a mean of 5.0 years at the time of the baseline contact. 
The prevalence of prescription opioid dependence in the past year was 3.4%. On average, 
frequency of reported NMPOU in the past 90 days was 31.0 days. Oral intact administration 
was the most commonly reported method of prescription opioid use (94.1%), however, 
substantial proportions reported alternate routes as well, including oral tampered 
administration (22.3%), and intranasal (9.0%). More than one-quarter (26.6%) reported 
taking prescription opioids by any alternate route in the past 90 days.
A total of 25 NMPOU misusers were prospectively observed to start using heroin over the 
12-month follow-up period with a survival rate of .90. Most heroin initiators (60%) began 
using heroin at the 3-month interval, 24% started to use heroin at the 6-month interval, and 
16% reported initial heroin use at the 12-month interval. Comparatively, only one participant 
without baseline NMPOU indicated heroin onset at follow-up (data not shown).
As shown in Table 1, univariable comparisons found several differences in baseline 
characteristics between heroin initiators (N=25) and non-initiators (N=298), though 
demographic characteristics were uniformly not associated with heroin initiation in this 
sample. The likelihood of heroin initiation at follow up was significantly higher among 
NMPO users reporting current physical health problems at baseline: those with severe pain 
(X2 = 2.65, p=.10) and those reporting impaired physical functioning (X2 = 3.11, p=.08) 
were more likely to initiate heroin compared to their counterparts without these 
impairments.
In terms of substance use, the likelihood of heroin initiation at follow up was higher among 
more frequent users of LSD (t=−3.04; p<.01). Participants with a lifetime history of drug 
overdose or emergency were also more likely to report initiating heroin at follow-up 
compared to their counterparts without an overdose experience (X2=3.64; p=.06).
Several features of NMPOU displayed significant associations with heroin initiation. 
Participants reporting more days of current NMPOU has a higher likelihood of initiating 
heroin during the follow-up period (t=−1.63; p=.10). Taking prescription opioids by oral 
tampering methods was associated with higher likelihood of heroin initiation at follow-up 
(X2=7.37; p<.01). In addition, participants whose primary method of prescription opioid 
acquisition involved a medical source were more likely to report heroin initiation at follow-
up than those without a medical source (X2=7.89; p<.01).
Results of the Cox proportional hazard regression predicting initial heroin use are shown in 
Table 2. Controlling for model covariates, three substance-related behaviors emerged as 
significant predictors of heroin initiation: LSD use, accessing prescription opioids through a 
medical source, and ingestion of orally tampered prescription opioids. Specifically, each 
additional day of using LSD increased the hazard of initiating heroin use by 3%, controlling 
for model covariates. Those accessing prescription opioids through a medical source were 
about 5 times more likely to initiate heroin use than participants who accessed prescription 
opioids through other sources. Those whose route of administration of prescription opioids 
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involved oral tampering were about three times more likely to initiate heroin use than those 
reporting other routes of administration. There was no association between model covariates 
(experimental arm, age, gender, race/ethnicity) and likelihood of heroin initiation.
4.0 Discussion
This prospective study documented heroin initiation among 7.7% of our young adult sample 
in the 12 month follow up observation period, suggesting a high level of vulnerability for 
transition to heroin among NMPO using club goers. The present study adds to the emerging 
literature on trajectories of NMPOU, and resonates with recent findings identifying specific 
NMPOU behaviors, such as frequency of nonmedical use and route of administration, as 
predictive of heroin use onset (Carlson et al., 2016).
In the univariable comparisons, we found that reported severe pain and physical health 
problems were associated with higher likelihood of heroin initiation at follow-up. These 
findings are consistent with existing observational data on the associations of NMPOU and 
physical health co-morbidities (Alford et al., 2015; Blanco et al., 2016; Cicero et al., 2012b; 
Levi-Minzi et al., 2013; McCabe et al., 2007), and lends support to the idea that self-
medication of untreated or under-treated health problems contributes to NMPOU. Although 
the present study did not collect information on motivation for NMPOU, Carlson and 
colleagues (2016) found that self-medication among NMPO users was not associated with 
heroin use initiation, whereas use to “get high” was.
Frequency of NMPOU may represent a good marker of opioid problem severity, spanning 
from episodic use to persistent use. In our young adult sample, the more frequent NMPO 
users had higher likelihood of heroin initiation in univariable analyses, consistent with 
findings of other research (Carlson et al., 2016; Jones, 2013). More frequent or daily use of 
opioids may suggest the development of tolerance and dependence (Daniulaitye et al., 2006, 
Haracopos et al., 2016), which drives the need to acquire more opioids and increases 
availability and cost pressures on users (Cicero et al., 2014).
At the univariable level we also found that lifetime history of drug overdose or drug 
emergency was associated with higher likelihood of heroin initiation. Interestingly, the drugs 
most often mentioned at baseline as involved in emergency episode(s) were alcohol, cocaine, 
and/or prescription sedatives, rather than prescription opioids. This may be an indicator that 
a subset of our young adult sample has particularly risky patterns of poly-drug use and 
concomitant experimentation with multiple substances, which is associated with future 
heroin initiation. Prior research has demonstrated that previous alcohol and/or other drug 
use, as well as patterns of poly-drug use, increase the likelihood of NMPOU (Edlund et al., 
2010; Wu and Howard, 2007).
In line with other emerging research, our findings indicate that route of administration is a 
key factor in opioid transitions (Carlson et al., 2016; Lankenau et al., 2012), and may 
represent an important target for prevention and intervention efforts. As previously observed, 
the reinforcing effects of opioids are heightened by rapid delivery through altered routes, 
and individuals often initiate orally and move to more efficient routes, such as snorting and 
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smoking, as tolerance develops (Compton and Volkow, 2006; Compton et al., 2016; Volkow 
and McLellan, 2016). Our findings extend prior research by documenting that oral 
tampering methods are a very common alternate route of administration, and may be an 
early antecedent to intranasal and injection use.
Another unique finding of this study is the significant association between primary source of 
prescription opioid acquisition and the onset of heroin use. Although source of opioid 
diversion has been related to opioid problem severity and progression in prior research 
(Cicero et al., 2011; Lankenau et al., 2012), the present study demonstrated that participants 
who reported acquiring prescription opioids for nonmedical use through a primary medical 
source had substantially higher odds of endorsing heroin initiation at follow-up. While 
dealers and sharing/trading medications represented much more common methods of opioid 
acquisition in our sample, a primary medical source for opioids conferred higher odds of 
heroin onset. Prior research found that NMPO users in Florida relied heavily on pain clinics 
and other medical sources for consistent access to opioid medications (Rigg et al., 2010); 
such access may be key in the development of problematic use and dependence. Although 
speculative, our findings may be indicative of the changing landscape of reduced access to 
prescription opioids in Florida through doctors and pain clinics (Delcher et al., 2015; Rutlow 
et al., 2015; Surratt et al., 2014), such that users are increasingly driven to informal, street-
based drug markets where heroin is more available. Heroin availability and purity was 
increasing nationally, and in South Florida, during the time period of study data collection 
(Finklea, 2015).
4.1 Limitations
Our study has several limitations. First, while our sample is generally representative of the 
gender and race/ethnic composition of the Miami area, it is unclear whether our findings are 
generalizable to community-based young adult populations in different geographic and 
cultural settings, or those who attend club venues in different contexts. Because study 
eligibility required nonmedical use of a psychoactive prescription medication at least once in 
the past 3 months, our bar for study entry was fairly high for nonmedical prescription drug 
use criteria, which may limit generalizability to other club-going samples. Although other 
U.S.-based studies of club drug users indicate common NMPOU (Kurtz et al., 2005; Kelly et 
al., 2013; 2015), prevalence in the present study surpassed these, suggesting that our heavily 
poly-drug-involved sample that may not be typical of club-going young adults. The 
influence of NMPOU by injection is also unclear and warrants future research, as only one 
study participant reported this route of administration. In addition, our data were gathered 
exclusively from participant self-reports, which have inherent weaknesses in terms of 
potentially inaccurate recall or biased reporting. Given the high levels of substance use 
reported, however, and the consistency of reports across CAPI and ACASI modalities, 
underreporting of drug use would appear to be minimal. As an additional point, outcome 
data were collected in the context of a low-intensity assessment intervention trial, rather than 
an observational study. As such, the longitudinal data on heroin initiation we report occurred 
after exposure to a low-dose intervention, which may have reduced the proportion initiating 
heroin from that of a truly untreated sample. Nevertheless, the study intervention was limited 
to a one-session interview assessment, which had no specific focus on NMPOU, but 
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gathered general information on patterns of drug use, sexual risk, physical and mental health 
status. Finally, the observed associations between features of NMPOU and subsequent 
heroin use may be partially attributable to environmental factors, such as legislative and 
policy efforts influencing availability and supply, which were unexamined in the current 
study.
4.2 Implications
Limitations aside, this study reports robust estimates from a large young adult sample with 
prevalent NMPOU. Our findings contribute to the long-standing discussion of prescription 
opioids as potential precursors to heroin use (Mars et al., 2014; Muhuri et al., 2013; Siegal et 
al., 2003), and provide new insights into the repertoire of behavioral factors that influence 
transition to heroin among NMPO users in a sample of young adult club goers. We 
documented heroin initiation among 7.7% of our young adult sample in a one year 
observation period, which resonates with recent estimates from other studies (Carlson et al., 
2016), and indicates elevated vulnerability for transition to heroin among NMPO using club 
goers. Given that our young club-going sample was heavily poly-drug-involved and 
transitioned to heroin at an alarming rate, more research would appear warranted to examine 
whether unique aspects of the club culture contribute to the acceleration of this transition, or 
whether the findings of the association between NMPOU and heroin initiation are largely 
context independent. Future research should also examine the viability of mounting targeted 
health promotion or harm reduction activities for this population in various settings, 
including club venues. Although prior work has documented challenges with health 
messaging within high-volume urban club settings (Kurtz et al., 2013), the adverse 
consequences of substance use among this young population require intervention approaches 
that are feasible to implement in settings where members of this population are routinely 
found. Exploring novel methods for disseminating NMPOU-related harm reduction 
information, such as risks of opioid tampering, to this targeted group would appear to be a 
key priority.
The importance of oral tampering methods in our young adult sample of club drug users, 
and the association with heroin onset within one year, may indicate the need for further 
examination of the role of abuse deterrent formulations (ADFs) in opioid prevention efforts. 
It is conceivable that more widespread development of ADFs may have a significant role in 
preventing shifts in route of administration, particularly among initially opportunistic, young 
NMPO users. Pilot data from young adults entering detoxification programs for opioid 
dependence in South Florida suggest that a substantial proportion of young adults are now 
initiating NMPOU through alternate routes, wholly bypassing oral use (Levi-Minzi et al., 
2015), a pattern that is potentially amenable to reduction with more widespread use of 
ADFs. Although the role of ADFs in opioid prevention efforts is somewhat controversial 
(Cicero and Ellis, 2015; Kolodny et al., 2015) our data indicate potential benefits of ADFs in 
limiting nonmedical opioid initiation through alternate routes, and reducing tampering in 
novice, experimental and opportunistic young opioid users prior to the onset of opioid 
dependence. There is a clear need for further controlled studies on patterns and trajectories 
in routes of opioid administration, which would identify specific intervention points and 
strategies along the trajectory of NMPOU (Carlson et al., 2016; Haracopos et al., 2016).
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Highlights
• Young adults in the club scene have high levels of nonmedical prescription 
opioid use
• Heroin onset occurred in 7.7% of nonmedical opioid users by 12 month 
follow up
• Opioid ingestion through oral tampering methods is predictive of heroin 
initiation
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Table 1
Baseline Characteristics of NMPO Users
Total
Initiated Heroin Use
No Yes
N (%) N (%) N (%)
323 (100.0%) 298 (92.3%) 25 (7.7%)
Demographics
Age:  18–24
 25–29
 30+
 mean(SD)
176 (54.5%)
78 (24.1%)
69 (21.4%)
25.0 (5.24)
166 (94.3%)
68 (87.2%)
64 (92.8%)
25.0 (5.2)
10 (5.7%)
10 (12.8%)
5 (7.2%)
25.8 (5.4)
Gender:  Female 150 (46.4%) 140 (93.3%) 10 (6.7%)
Race/ethnicity:  Hispanic 210 (65.0%) 196 (93.3%) 14 (6.7%)
 African American/Black 77 (23.8%) 69 (89.6%) 8 (10.4%)
 White 26 (8.0%) 23 (88.5%) 3 (11.5%)
 Other 10 (3.1%) 10 (100.0%) 0 (0.0%)
Health
Significant pain (past 90 days) 96 (29.7%) 85 (88.5%) 11 (11.5%)+
Health problem interference (past 90 days) 71 (22.0%) 62 (87.3%) 9 (12.7%)+
HIV-positive 3 (0.9%) — —
HCV-positive 1 (0.3%) — —
Severe mental distress (past year) 157 (48.6%) 142 (90.4%) 15 (9.6%)
Substance use (days in past 90)
Days Alcohol  mean(SD) 48.4 (25.2) 48.0 (25.3) 52.9 (24.3)
Days Marijuana  mean(SD) 63.2 (31.6) 62.9 (31.4) 66.7 (34.4)
Days Cocaine (powder)  mean(SD) 31.7 (26.0) 31.6 (26.2) 33.9 (24.3)
Days Crack cocaine  mean(SD) 3.7 (14.2) 3.5 (13.7) 5.8 (19.5)
Days Ecstasy  mean(SD) 31.9 (23.8) 31.7 (23.9) 33.5 (22.9)
Days Heroin  mean(SD) 0.0 (0.0) — —
Days LSD  mean(SD) 5.5 (11.8) 5.0 (10.4) 12.3 (21.5)**
Days Methamphetamine  mean(SD) 1.9 (7.8) 2.0 (8.0) 0.9 (2.3)
Days Prescription stimulants  mean(SD) 10.1 (18.5) 10.2 (18.5) 8.5 (19.3)
Days Prescription sedatives  mean(SD) 33.4 (28.8) 33.2 (28.8) 36.0 (29.4)
Days Prescription antidepressants  mean(SD) 6.7 (17.9) 6.5 (17.6) 8.7 (21.9)
Days Prescription antipsychotics  mean(SD) 5.7 (16.3) 5.8 (16.6) 4.8 (13.2)
Substance-related problems
Substance dependence (past year) 218 (67.5%) 198 (90.8%) 20 (9.2%)
Drug overdose or drug-related emergency (lifetime) 68 (21.1%) 59 (86.8%) 9 (13.2%)+
Substance abuse treatment (lifetime) 88 (27.2%) 80 (90.9%) 8 (9.1%)
Drug injection (lifetime) 13 (4.0%) 11 (84.6%) 2 (15.4)
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Total
Initiated Heroin Use
No Yes
N (%) N (%) N (%)
323 (100.0%) 298 (92.3%) 25 (7.7%)
Nonmedical prescription opioid use (NMPOU)
Years of NMPOU  mean(SD) 5.0 (4.1) 5.0 (4.1) 5.6 (4.0)
Age at first NMPOU  mean(SD) 20.0 (4.6) 20.0 (4.6) 20.2 (4.2)
Days NMPOU (past 90)  mean(SD) 31.0 (25.8) 30.3 (25.7) 39.1 (26.8) +
Prescription opioid dependence (past year) 11 (3.4%) 8 (72.7%) 3 (27.3%)
Routes of NMPO Administration:  Oral 304 (94.1%) 279 (91.8%) 25 (8.2%)
 Oral, tampered 72 (22.3%) 58 (84.1%) 11 (15.9%)*
 Smoking 10 (3.1%) 9 (90.0%) 1 (10.0%)
 Snorting 29 (9.0%) 25 (86.2%) 4 (13.8%)
 Injecting 1 (0.3%) — —
 Any alternate route 86 (26.6%) 74 (86.0%) 12 (14.0%)*
Primary Source of Opioids:  Medical 15 (4.6%) 11 (73.3%) 4 (26.7%)*
 Theft 10 (3.1%) 9 (90.0%) 1 (10.0%)
 Dealer/Club/Street buy 208 (64.4%) 192 (92.3%) 16 (7.7%)
 Sharing/Trading 89 (27.6%) 85 (95.5%) 4 (4.5%)
 Other 1 (0.3%) — —
+Notes: p≤.10;
*p≤.05;
**p≤.01
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